Evaluation of the Feasibility, Safety, Initial Efficacy and Clinical Usability of FuseX Anti-Adhesion System

NCT03820713 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Reduction of Postoperative Adhesions

Interventions

PROCEDURE: Concentrate of plasma coagulation factors
PROCEDURE: 0.9% saline

Sponsor

Eio Biomedical Ltd.